fluorometholone has been researched along with nepafenac in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Miyake, G; Miyake, K; Numaga, J; Ota, I | 1 |
| Chuck, RS; Zhang, C; Zhu, L | 1 |
| Chen, X; Li, SS; Wang, HH; Wang, YL; Zhang, DW | 1 |
1 review(s) available for fluorometholone and nepafenac
| Article | Year |
|---|---|
Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Cataract; Cataract Extraction; Dexamethasone; Diclofenac; Fluorometholone; Humans; Macular Edema; Treatment Outcome | 2023 |
1 trial(s) available for fluorometholone and nepafenac
| Article | Year |
|---|---|
Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Blood-Aqueous Barrier; Double-Blind Method; Female; Fluorescein Angiography; Fluorometholone; Glucocorticoids; Humans; Lens Implantation, Intraocular; Macular Edema; Male; Microsurgery; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Photometry; Postoperative Complications; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2011 |
1 other study(ies) available for fluorometholone and nepafenac
| Article | Year |
|---|---|
Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Botulinum Toxins; Botulinum Toxins, Type A; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Fluorometholone; Glucocorticoids; Interleukin-1beta; Ketorolac; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Phenylacetates; Tears; Tumor Necrosis Factor-alpha | 2012 |